The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124473682 12447368 2 F 2013 20160718 20160608 20160804 EXP US-GLAXOSMITHKLINE-US2016073716 GLAXOSMITHKLINE 72.89 YR M Y 0.00000 20160804 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124473682 12447368 1 PS FLOVENT DISKUS FLUTICASONE PROPIONATE 1 Respiratory (inhalation) 110 MCG 1 PUFF(S), BID Y UNKNOWN 21433 1 DF BID
124473682 12447368 2 SS FLOVENT DISKUS FLUTICASONE PROPIONATE 1 Respiratory (inhalation) 220 MCG 1 PUFF(S), BID Y 21433 1 DF BID
124473682 12447368 3 SS INCRUSE ELLIPTA UMECLIDINIUM BROMIDE 1 Respiratory (inhalation) 1 PUFF(S), QD UNKNOWN 0 1 DF INHALATION POWDER QD
124473682 12447368 4 SS INCRUSE ELLIPTA UMECLIDINIUM BROMIDE 1 0 INHALATION POWDER
124473682 12447368 5 SS PROVENTIL ALBUTEROL 1 Respiratory (inhalation) 2 PUFF(S), U Y UNKNOWN 0 2 DF
124473682 12447368 6 SS ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) 250/50 MCG 1 PUFF(S), BID 6ZP4187 0 1 DF INHALATION POWDER BID
124473682 12447368 7 SS MONTELUKAST MONTELUKAST SODIUM 1 UNK UNK, U UNKNOWN 0
124473682 12447368 8 SS QUINAPRIL. QUINAPRIL 1 Oral 10 MG, QD UNKNOWN 0 10 MG QD
124473682 12447368 9 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 U 0
124473682 12447368 10 C BETA SITOSTEROL 2 U 0
124473682 12447368 11 C POLICOSANOL 2 U 0
124473682 12447368 12 C PREDNISONE. PREDNISONE 1 U 0
124473682 12447368 13 C SAW PALMETTO SAW PALMETTO 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124473682 12447368 1 Asthma
124473682 12447368 3 Asthma
124473682 12447368 4 Hypertension
124473682 12447368 5 Asthma
124473682 12447368 6 Asthma
124473682 12447368 8 Hypertension

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
124473682 12447368 Adverse event
124473682 12447368 Blood creatinine increased
124473682 12447368 Blood potassium increased
124473682 12447368 Bronchitis
124473682 12447368 Chronic obstructive pulmonary disease
124473682 12447368 Depression
124473682 12447368 Device use error
124473682 12447368 Drug dose omission
124473682 12447368 Drug ineffective
124473682 12447368 Dyspnoea
124473682 12447368 Exercise tolerance decreased
124473682 12447368 Fatigue
124473682 12447368 Insomnia
124473682 12447368 Intentional product misuse
124473682 12447368 Micturition urgency
124473682 12447368 Oedema peripheral
124473682 12447368 Peak expiratory flow rate decreased
124473682 12447368 Spirometry abnormal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124473682 12447368 1 2002 0
124473682 12447368 2 201605 0
124473682 12447368 3 201605 0
124473682 12447368 5 1991 0
124473682 12447368 6 201605 0
124473682 12447368 8 2011 0